NYSEARCA:MARM SHL Telemedicine Ltd FT Vest U. (MARM) Price, Holdings, & News $32.39 +0.08 (+0.25%) As of 08/22/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipBuy This Stock About SHL Telemedicine Ltd FT Vest U. (NYSEARCA:MARM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MARM alerts:Sign Up Key Stats Today's Range$32.34▼$32.4050-Day Range$31.88▼$32.3952-Week Range$29.92▼$32.40Volume1,499 shsAverage Volume21,022 shsMarket Capitalization$132.80 millionAssets Under Management$1.46 millionDividend YieldN/ANet Expense Ratio0.00%Aggregate RatingN/A ETF Overview The FT Vest U.S. Equity Max Buffer ETF – March (MARM) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to match the price returns of SPDR S&P 500 ETF Trust using a buffer and upside cap strategy, over a specific holdings period. MARM was launched on Mar 26, 2024 and is issued by First Trust. Read More SHL Telemedicine Ltd FT Vest U. ExpensesTypeMARMLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.00%0.58%0.56%0.51%0.53%Other Expenses0.00%0.27%0.56%0.59%0.56%Total Expense0.00%0.65%0.76%0.74%0.73%Fee Waiver0.00%-0.23%-0.66%-0.71%-0.63%Net Expense0.00%0.62%0.63%0.58%0.60% Receive MARM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SHL Telemedicine Ltd FT Vest U. and its competitors with MarketBeat's FREE daily newsletter. Email Address MARM ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MARM ETF - Frequently Asked Questions How have MARM shares performed this year? SHL Telemedicine Ltd FT Vest U.'s stock was trading at $30.88 at the beginning of the year. Since then, MARM shares have increased by 4.9% and is now trading at $32.39. How do I buy shares of SHL Telemedicine Ltd FT Vest U.? Shares of MARM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details Issuer Fund NameFT VEST US EQ MAX BUF MAR Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MARM Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$1.46 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares4,100,000Beta0.31 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report Top 5 MARM HoldingsOption on SPDR® S&P 500® ETF Trust Mar26Holding Weight: 106.46%Option on SPDR® S&P 500® ETF Trust Mar26Holding Weight: 2.21%Dreyfus Govt Cm Inst 289Holding Weight: 0.82%CashHolding Weight: 0.00%Option on SPDR® S&P 500® ETF Trust Mar26Holding Weight: -9.49%Full Holdings Details This page (NYSEARCA:MARM) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SHL Telemedicine Ltd FT Vest U. Please log in to your account or sign up in order to add this asset to your watchlist. Share SHL Telemedicine Ltd FT Vest U. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access